Benitec Biopharma Inc.

Last updated September 27, 2026

Favorite this organization

Organization details

Legal name: Benitec Biopharma Inc.
Ownership: Public
Status: Active
Sector (GICS): Health Care
SIC code: 2834 — Pharmaceutical Preparations
Jurisdiction of incorporation: Delaware
Headquarters city: Hayward
Headquarters state / province: California
Headquarters country: United States
Fiscal year end: June
Ticker symbol: BNTC
Primary stock exchange: Nasdaq

Identifiers

SEC CIK: 0001808898

Board of directors

Follow this board

Aaron Cowen · Director
Since 2024
David Matthew Friedman · Director
Since 2026
Edward F. Smith · Director
Since 2023
J. Kevin Buchi · Director
Since 2023
Jerel A. Banks · Director · Chief Executive Officer
Since 2023
Kishan Mehta · Director
Since 2024
Megan Boston · Director · Chief Financial Officer
Since 2023
Peter Francis · Director
Since 2023
Sharon Mates · Director
Since 2025

Chief executives

Jerel A. Banks · Chief Executive Officer

Dates unknown

Director election results

Annual meeting of December 1, 2025. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Megan Boston

97.5%
Jerel A. Banks

99.5%

Board connections

5 of this board's directors also sit on 5 other boards. 5 are in the same sector.

Shared director Other board Same sector

Veradermics Incorporated Same sector
via Aaron Cowen and David Matthew Friedman
Amneal Pharmaceuticals Inc. Same sector
via J. Kevin Buchi
Avalyn Pharma Inc. Same sector
via David Matthew Friedman
Biohaven Ltd. Same sector
via Kishan Mehta
Seaport Therapeutics Inc. Same sector
via Sharon Mates

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months: $2,442,105; 12 purchases by 1 insider
Sold, last 12 months: $0; 0 sales by 0 insiders

Date	Insider	Transaction	Shares	Price	Value
Jun 29, 2026	J. Kevin Buchi Director	Gift	−51,813	—	—
Dec 29, 2025	Aaron Cowen Director, 10% owner	Open-market purchase	+65,800	$13.44	$884,352
Dec 29, 2025	Aaron Cowen Director, 10% owner	Open-market purchase	+11,587	$13.44	$155,729
Dec 26, 2025	Aaron Cowen Director, 10% owner	Open-market purchase	+14,320	$13.10	$187,592
Dec 26, 2025	Aaron Cowen Director, 10% owner	Open-market purchase	+2,516	$13.10	$32,960
Dec 23, 2025	Aaron Cowen Director, 10% owner	Open-market purchase	+42,600	$12.85	$547,410
Dec 23, 2025	Aaron Cowen Director, 10% owner	Open-market purchase	+7,400	$12.85	$95,090
Dec 22, 2025	Aaron Cowen Director, 10% owner	Open-market purchase	+16,650	$12.08	$201,132
Dec 22, 2025	Aaron Cowen Director, 10% owner	Open-market purchase	+2,892	$12.08	$34,935
Dec 19, 2025	Aaron Cowen Director, 10% owner	Open-market purchase	+13,950	$11.48	$160,146
Dec 19, 2025	Aaron Cowen Director, 10% owner	Open-market purchase	+2,434	$11.48	$27,942
Dec 18, 2025	Aaron Cowen Director, 10% owner	Open-market purchase	+8,700	$11.24	$97,788
Dec 18, 2025	Aaron Cowen Director, 10% owner	Open-market purchase	+1,515	$11.24	$17,029
Nov 7, 2025	SUVRETTA CAPITAL MANAGEMENT, LLC Director, 10% owner	Open-market purchase	+730,370	$13.50	$9,859,995
Nov 7, 2025	SUVRETTA CAPITAL MANAGEMENT, LLC Director, 10% owner	Open-market purchase	+751,111	$13.50	$10,139,999

Peers

Compare boards

Organizations in the same sector, closest in location and size first.

3M Company NYSE: MMM · ST Paul, United States Organization ABVC BioPharma Inc. Nasdaq: ABVC · Fremont, United States Organization ACADIA Pharmaceuticals Inc. Nasdaq: ACAD · SAN Diego, United States Organization ADMA Biologics Inc Nasdaq: ADMA · Ramsey, United States Organization

Questions about Benitec Biopharma Inc.

Who is the CEO of Benitec Biopharma Inc.?

Jerel A. Banks is Benitec Biopharma Inc.'s Chief Executive Officer.

How many directors are on Benitec Biopharma Inc.'s board?

Benitec Biopharma Inc.'s board has 9 directors: Aaron Cowen, David Matthew Friedman, Edward F. Smith, J. Kevin Buchi, Jerel A. Banks, Kishan Mehta, Megan Boston, Peter Francis and Sharon Mates.

Are Benitec Biopharma Inc. insiders buying or selling shares?

Over the last 12 months, Benitec Biopharma Inc. insiders bought $2.4 million of shares in 12 purchases and made no open-market sales on the open market, as reported to the SEC on Forms 4 and 5.

How is Benitec Biopharma Inc. connected to…? → Spot something wrong? Report a correction

Embed this board on your site

Paste this where the board should appear. It always shows the current directors and links back here.

<div data-bod-board="benitec-biopharma-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>

Reviews (0)

No reviews yet. Be the first to write one.